Figure 3
From: Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury
Simvastatin decreases the level of plasma HBP in patients with ALI. (A) Patients with ALI received either placebo or 80 mg simvastatin. Thereafter, plasma samples were collected at day 3 and day 7, and the levels of HBP were measured by ELISA. Baseline plasma HBP levels were measured before drug administration (day 0). (B) The fold change of HBP at day 7 versus day 0 was expressed for patients who have received placebo or 80 mg simvastatin. (C) The data in (A) were corrected to neutrophil counts. (D) The fold change of HBP corrected for neutrophil counts at day 7 versus day 0 was expressed for patients who have received placebo or 80 mg simvastatin.